Centre d'Information et de documentation du CRA Rhône-Alpes
CRA
Informations pratiques
-
Adresse
Centre d'information et de documentation
du CRA Rhône-Alpes
Centre Hospitalier le Vinatier
bât 211
95, Bd Pinel
69678 Bron CedexHoraires
Lundi au Vendredi
9h00-12h00 13h30-16h00Contact
Tél: +33(0)4 37 91 54 65
Mail
Fax: +33(0)4 37 91 54 37
-
Détail de l'auteur
Auteur Diana MESSINA |
Documents disponibles écrits par cet auteur (1)
Faire une suggestion Affiner la recherche
A Familial Heterozygous Null Mutation of MET in Autism Spectrum Disorder / Nelle LAMBERT in Autism Research, 7-5 (October 2014)
[article]
Titre : A Familial Heterozygous Null Mutation of MET in Autism Spectrum Disorder Type de document : Texte imprimé et/ou numérique Auteurs : Nelle LAMBERT, Auteur ; Vanessa WERMENBOL, Auteur ; Bruno PICHON, Auteur ; Sandra T. ACOSTA, Auteur ; Jelle VAN DEN AMEELE, Auteur ; Camille PERAZZOLO, Auteur ; Diana MESSINA, Auteur ; Maria-Franca MUSUMECI, Auteur ; Barbara DESSARS, Auteur ; Anne DE LEENER, Auteur ; Marc ABRAMOWICZ, Auteur ; Catheline VILAIN, Auteur Article en page(s) : p.617-622 Langues : Anglais (eng) Mots-clés : autism spectrum disorder c-MET social brain neurodevelopment Index. décimale : PER Périodiques Résumé : Autism spectrum disorder (ASD) results from interactions of genetic and environmental factors. The MET proto-oncogene has been identified as a candidate gene for autism susceptibility, and is implicated in neurodevelopment and social brain circuitry. Here, we describe the first case of a familial mutation of MET, consisting of an interstitial genomic deletion removing exons 12 through 15, causing a frameshift and premature stop codon, with evidence of nonsense-mediated mRNA decay. On the other allele, patients carried the C allele of the MET promoter rs1858830 polymorphism, known to decrease MET expression and previously associated with autism susceptibility. The heterozygous mutation was associated with autism in one patient, and language and social impairment in a sibling. Our observations delineate the phenotypic spectrum associated with a clearly defined, very likely complete loss of function mutation of MET. Incomplete penetrance in this family was consistent with MET as a partial susceptibility gene for ASD. Implication of MET in normal and pathological brain development opens new perspectives for understanding the pathophysiology of autism and for eventual therapeutical clues. Autism Res 2014, 7: 617–622. © 2014 International Society for Autism Research, Wiley Periodicals, Inc. En ligne : http://dx.doi.org/10.1002/aur.1396 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=241
in Autism Research > 7-5 (October 2014) . - p.617-622[article] A Familial Heterozygous Null Mutation of MET in Autism Spectrum Disorder [Texte imprimé et/ou numérique] / Nelle LAMBERT, Auteur ; Vanessa WERMENBOL, Auteur ; Bruno PICHON, Auteur ; Sandra T. ACOSTA, Auteur ; Jelle VAN DEN AMEELE, Auteur ; Camille PERAZZOLO, Auteur ; Diana MESSINA, Auteur ; Maria-Franca MUSUMECI, Auteur ; Barbara DESSARS, Auteur ; Anne DE LEENER, Auteur ; Marc ABRAMOWICZ, Auteur ; Catheline VILAIN, Auteur . - p.617-622.
Langues : Anglais (eng)
in Autism Research > 7-5 (October 2014) . - p.617-622
Mots-clés : autism spectrum disorder c-MET social brain neurodevelopment Index. décimale : PER Périodiques Résumé : Autism spectrum disorder (ASD) results from interactions of genetic and environmental factors. The MET proto-oncogene has been identified as a candidate gene for autism susceptibility, and is implicated in neurodevelopment and social brain circuitry. Here, we describe the first case of a familial mutation of MET, consisting of an interstitial genomic deletion removing exons 12 through 15, causing a frameshift and premature stop codon, with evidence of nonsense-mediated mRNA decay. On the other allele, patients carried the C allele of the MET promoter rs1858830 polymorphism, known to decrease MET expression and previously associated with autism susceptibility. The heterozygous mutation was associated with autism in one patient, and language and social impairment in a sibling. Our observations delineate the phenotypic spectrum associated with a clearly defined, very likely complete loss of function mutation of MET. Incomplete penetrance in this family was consistent with MET as a partial susceptibility gene for ASD. Implication of MET in normal and pathological brain development opens new perspectives for understanding the pathophysiology of autism and for eventual therapeutical clues. Autism Res 2014, 7: 617–622. © 2014 International Society for Autism Research, Wiley Periodicals, Inc. En ligne : http://dx.doi.org/10.1002/aur.1396 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=241